Bank Of Montreal Sage Therapeutics, Inc. Transaction History

Bank Of Montreal

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$27.52 - $37.99 $872,741 - $1.2 Million	31,713 Added 326.67%	41,421 $1.49 Million
Q1 2022 May 12, 2022	SELL	$30.71 - $45.71 $572,188 - $851,668	-18,632 Reduced 65.74%	9,708 $336,000
Q4 2021 Feb 11, 2022	SELL	$37.06 - $47.11 $6.29 Million - $8 Million	-169,782 Reduced 85.7%	28,340 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$40.26 - $57.37 $7.98 Million - $11.4 Million	198,122 New	198,122 $8.92 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $415M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.